Metropolis Healthcare Limited (NSE:METROPOLIS)
India flag India · Delayed Price · Currency is INR
575.00
+6.30 (1.11%)
Nov 4, 2026, 3:30 PM IST

Metropolis Healthcare Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
2,2431,9001,4501,2781,4292,142
Depreciation & Amortization
1,1471,125892.3846.45806.27562.1
Other Amortization
212.08212.08194.5298.2385.8970.13
Loss (Gain) From Sale of Assets
5.296.83-17.59--0.080.16
Asset Writedown & Restructuring Costs
----1.352.22
Loss (Gain) From Sale of Investments
-86.08-33.84-75.06-11.56-6.78-4.26
Stock-Based Compensation
162.8480.7470.0814.162.8568.57
Provision & Write-off of Bad Debts
260.56278.7397.09113.52-21.72-28.48
Other Operating Activities
540.59469.28173.58247.21103.19-115.54
Change in Accounts Receivable
-346.57-489.68-118.89-123.7157.72115.87
Change in Inventory
-82.2332.3218.7558.9865.15-79.37
Change in Accounts Payable
217.05-22.848.3857-53.12-165.07
Change in Other Net Operating Assets
168.92-52.01-105.3862.24-98.64-35.41
Operating Cash Flow
4,4423,5072,6272,6412,4712,533
Operating Cash Flow Growth
63.51%33.47%-0.50%6.87%-2.44%1.70%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-340.05-434.89-434.1-637.61-526.34-306.63
Sale of Property, Plant & Equipment
2.72.720-1.49-
Cash Acquisitions
-147.14-1,134-1,312-6.5-4.51-6,379
Sale (Purchase) of Intangibles
19.29-76.95-252.02---
Investment in Securities
-2,409-606.66-48.32-271.66932.29-800.44
Other Investing Activities
32.8918.6915.7721.6565.01110.62
Investing Cash Flow
-2,841-2,231-2,011-894.12467.94-7,376

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-45.37---6,000
Total Debt Issued
-19.8245.37---6,000
Long-Term Debt Repaid
--812.66-680.87-1,382-2,242-3,791
Lease Payments
-780.59-812.66-673.37-591.74-453.53-375.33
Total Debt Repaid
-797.8-812.66-680.87-1,382-2,242-3,791
Net Debt Issued (Repaid)
-817.62-767.29-680.87-1,382-2,2422,209
Issuance of Common Stock
9.060.070.10.031.8419.75
Common Dividends Paid
-414.62-207.29--204.96-409.69-409.38
Other Financing Activities
-263.05-178.43-185.57-224.8-273.24-194.48
Financing Cash Flow
-1,486-1,153-866.34-1,812-2,9231,625

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
70.524.639.83.2512.97-13.64
Miscellaneous Cash Flow Adjustments
-0.475.78.21-0-25.29
Net Cash Flow
185.02153.08-231.43-62.1528.53-3,206

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
4,1023,0722,1932,0031,9452,226
Free Cash Flow Growth
89.14%40.06%9.50%3.01%-12.65%0.84%
Free Cash Flow Margin
23.01%18.67%16.48%16.59%16.94%18.12%
Free Cash Flow Per Share
19.8114.8610.609.749.4610.82
Levered Free Cash Flow
3,4372,4281,5521,8401,2801,723
Unlevered Free Cash Flow
3,6052,5811,6681,9811,4481,846
Free Cash Flow After Leases
3,3222,2591,5201,4111,4911,851

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
244.03244.03185.57224.8273.24183.84
Cash Income Tax Paid
454.85454.85439.75373.84515.8825.12
Change in Working Capital
-42.83-532.17-157.1354.5271.11-163.98